0758 GMT - Parkway Life REIT is likely on a solid growth trajectory, DBS Group Research analysts say in a research report, as they maintain its buy rating on the REIT. The full earnings impact of the REIT's recent acquisition of a portfolio of French nursing homes is expected to emerge this year, the analysts say. Also, the rental upside for the REIT's Singapore hospitals should kick in from 2026, thanks to their master-lease renewal. Moreover, there's potential further upside to its Mount Elizabeth Orchard hospital's revenues post-asset enhancement initiative in 2026. However, DBS trims the unit's target price to S$4.75 from S$4.80 to reflect some adjusted assumptions. Units are 1.0% lower at S$3.94. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
February 10, 2025 02:58 ET (07:58 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。